DK1091733T3 - (-)-Pseudoephedrin som et sympatomimetisk lægemiddel - Google Patents

(-)-Pseudoephedrin som et sympatomimetisk lægemiddel

Info

Publication number
DK1091733T3
DK1091733T3 DK99959110T DK99959110T DK1091733T3 DK 1091733 T3 DK1091733 T3 DK 1091733T3 DK 99959110 T DK99959110 T DK 99959110T DK 99959110 T DK99959110 T DK 99959110T DK 1091733 T3 DK1091733 T3 DK 1091733T3
Authority
DK
Denmark
Prior art keywords
pseudoephedrine
present
free
substantially free
sympathomimetic drug
Prior art date
Application number
DK99959110T
Other languages
English (en)
Inventor
Anthony R Booth
William Sherman
Peter Raven
James L Caffrey
Thomas Yorio
Michael Forster
Patricia Gwirtz
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK1091733T3 publication Critical patent/DK1091733T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
DK99959110T 1998-07-01 1999-06-08 (-)-Pseudoephedrin som et sympatomimetisk lægemiddel DK1091733T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9145198P 1998-07-01 1998-07-01

Publications (1)

Publication Number Publication Date
DK1091733T3 true DK1091733T3 (da) 2006-04-03

Family

ID=22227855

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99959110T DK1091733T3 (da) 1998-07-01 1999-06-08 (-)-Pseudoephedrin som et sympatomimetisk lægemiddel

Country Status (8)

Country Link
US (1) US6495529B1 (da)
EP (1) EP1091733B1 (da)
AT (1) ATE311928T1 (da)
AU (1) AU772807B2 (da)
DE (1) DE69928806T2 (da)
DK (1) DK1091733T3 (da)
ES (1) ES2251246T3 (da)
WO (1) WO2000001379A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828351B2 (en) 2000-11-01 2004-12-07 Sention, Inc. Methods and compositions for regulating memory consolidation
US7619005B2 (en) 2000-11-01 2009-11-17 Cognition Pharmaceuticals Llc Methods for treating cognitive impairment in humans with Multiple Sclerosis
US20030232890A1 (en) 2000-11-01 2003-12-18 Sention, Inc. Methods for treating an impairment in memory consolidation
HUP0401630A2 (hu) * 2001-06-20 2004-12-28 Schering Corp. Antihisztaminok alkalmazása nazális vérbőség és orrdugulás kezelésére szolgáló gyógyszerkészítmény előállítására
AU2016201834A1 (en) * 2002-07-30 2016-04-14 Omeros Corporation Ophthalmologic irrigation solutions and method
CA2866848C (en) 2002-07-30 2017-01-03 Omeros Corporation Ophthalmologic irrigation solutions and method
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US9238073B2 (en) 2006-04-12 2016-01-19 Wyeth Llc Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
CA2775890C (en) * 2009-09-30 2016-06-21 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
CN107595793B (zh) 2012-11-30 2020-11-13 阿库拉制药公司 活性药物成分的自调节释放
US9616029B2 (en) 2014-03-26 2017-04-11 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release coated reservoir solid dosage form
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US5101015A (en) * 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
JPH06506684A (ja) * 1991-04-01 1994-07-28 メルク　エンド　カンパニー　インコーポレーテッド イブプロフェン−充血除去剤配合物

Also Published As

Publication number Publication date
DE69928806D1 (de) 2006-01-12
WO2000001379A1 (en) 2000-01-13
EP1091733A1 (en) 2001-04-18
US6495529B1 (en) 2002-12-17
AU772807B2 (en) 2004-05-06
EP1091733B1 (en) 2005-12-07
ATE311928T1 (de) 2005-12-15
ES2251246T3 (es) 2006-04-16
AU4335799A (en) 2000-01-24
DE69928806T2 (de) 2006-07-20

Similar Documents

Publication Publication Date Title
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
DK1091733T3 (da) (-)-Pseudoephedrin som et sympatomimetisk lægemiddel
DE60027463D1 (de) Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
HRP20030046B1 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
ATE282418T1 (de) Orale verabreichung wirksamer mengen von hyaluronsäure
NZ510887A (en) Formulations of fexofenadine for ocular and nasal delivery
NO20024646L (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
NO20051023L (no) Oral administrering av calcitonin
MX2021014161A (es) Metodos de tratamiento del sindrome de sjogren utilizando un inhibidor de la tirosina quinasa de bruton.
AR023687A1 (es) Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
DK1187611T3 (da) Oftalmiske histaminholdige sammensætninger og anvendelse deraf
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
SE9702066D0 (sv) A new salt
JP2003073303A (ja) 眼局所用液剤の清涼化作用の持続方法
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv
EA200300430A1 (ru) Новые фармацевтические композиции, содержащие эпинастин и псевдоэфедрин
WO1999048483A3 (en) (-)-phenylpropanolamine as a sympathomimetic drug
BR0316123A (pt) Formulação farmacêutica aquosa, uso de uma formulação farmacêutica aquosa, e, método de tratamento de um paciente com necessidade de tratamento antitrombótico
EA200500957A1 (ru) Применение l-допа, его производных и лекарственных средств, содержащих эти соединения, для профилактики психотических заболеваний
SE0002354D0 (sv) New formulation
PE20011042A1 (es) Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan
SE0102888D0 (sv) New formulation